Grifols SA

Sector: Biological Products Except Diagnostic Substances Region: Spain

Exchange/Ticker: Spanish Markets: GRF | OTC Bulletin Board: GIKLY | Spanish Markets: GRF.P | Nasdaq: GRFS

Company Description

Grifols SA operates as a fractionator of plasma derived blood products. It operates through the following segments: Bioessence, Hospital, Diagnostic, and Raw Materials. The Bioessence segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by Group companies earmarked for hospital pharmacy. The Diagnostic segment includes the marketing of diagnostic testing equipment, reagents, and other equipment. The Raw Materials segment includes the sale of intermediate biological products and the rendering of manufacturing services to third party companies. The company applies sophisticated science and technology to improve people's health and well-being through providing life-saving products and through giving employment to professionals around the world. It was founded on June 22, 1987 and is headquartered in Barcelona, Spain.

Similar to: BioTime, Inc., ALLENEX AB, Retrophin Inc

Featured Company

Fidelity China Special Situations Plc

Surrey, SU, GB

Fidelity China Special Situations Plc is an investment trust with the interest in investments in equities, index linked, equity linked,… Learn more →